CannaLean Biotechs Ltd., founded in 2017 and headquartered in Israel, is a company committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) and Chitosan that will potentially benefit millions of patients suffering from Dyslipidemia.

CannaLean Biotechs Ltd.
14-18 Hirsh St. Bnei-Brak,
ISRAEL

Phone: (972) 3 617-6173
Fax: (972) 3 617-6647

E-Mail: mail@cannaleanbio.com
Web: http://www.CannaLeanBio.com